(Q47643319)

4 February 2018

title

Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice (English)

1 reference

4 February 2018

enzyme replacement therapy

main subject

0 references

mucopolysaccharidosis type IIIA

1 reference

2

John J Hopwood

1 reference

4 February 2018

author name string

Briony L Gliddon

series ordinal

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

5 May 2004

1 reference

4 February 2018

published in

Pediatric Research

1 reference

4 February 2018

volume

56

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

65-72

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1203/01.pdr.0000129661.40499.12

exact match

0 references

cites work

Prevalence of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Management of mucopolysaccharidosis type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Structure of a human lysosomal sulfatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Amino acid residues forming the active site of arylsulfatase A. Role in catalytic activity and substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Enzyme-replacement therapy in mucopolysaccharidosis I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Caprine mucopolysaccharidosis IIID: a preliminary trial of enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Enzyme replacement therapy for murine mucopolysaccharidosis type VII

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Recombinant human sulphamidase: expression, amplification, purification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Developments of a water-maze procedure for studying spatial learning in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000129661.40499.12

10.1203/01.PDR.0000129661.40499.12

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

Dimensions Publication ID

0 references

1 reference

4 February 2018